BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 34079080)

  • 21. DDX3 interacts with USP9X and participates in deubiquitination of the anti-apoptotic protein MCL1.
    Lai MC; Chen YP; Li DA; Yu JS; Hung HY; Tarn WY
    FEBS J; 2022 Feb; 289(4):1043-1061. PubMed ID: 34606682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ubiquitin-specific protease 14 regulates cell proliferation and apoptosis in oral squamous cell carcinoma.
    Chen X; Wu J; Chen Y; Ye D; Lei H; Xu H; Yang L; Wu Y; Gu W
    Int J Biochem Cell Biol; 2016 Oct; 79():350-359. PubMed ID: 27592452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma.
    Sun Y; Wang S; Zhang X; Wu Z; Li Z; Ding Z; Huang X; Chen S; Jing Y; Zhang X; Ding L; Song Y; Sun G; Ni Y
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of MCL-1 Protein Stability Induced by MCL-1 Antagonists in B-Cell Malignancies.
    Tantawy SI; Sarkar A; Hubner S; Tan Z; Wierda WG; Eldeib A; Zhang S; Kornblau S; Gandhi V
    Clin Cancer Res; 2023 Jan; 29(2):446-457. PubMed ID: 36346691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deubiquitinase ubiquitin-specific protease 9X regulates the stability and function of E3 ubiquitin ligase ring finger protein 115 in breast cancer cells.
    Lu Q; Lu D; Shao ZM; Li DQ
    Cancer Sci; 2019 Apr; 110(4):1268-1278. PubMed ID: 30689267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant expression of deubiquitylating enzyme USP9X predicts poor prognosis in gastric cancer.
    Fu X; Xie W; Song X; Wu K; Xiao L; Liu Y; Zhang L
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):687-692. PubMed ID: 28274596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma.
    Pérez-Mancera PA; Rust AG; van der Weyden L; Kristiansen G; Li A; Sarver AL; Silverstein KA; Grützmann R; Aust D; Rümmele P; Knösel T; Herd C; Stemple DL; Kettleborough R; Brosnan JA; Li A; Morgan R; Knight S; Yu J; Stegeman S; Collier LS; ten Hoeve JJ; de Ridder J; Klein AP; Goggins M; Hruban RH; Chang DK; Biankin AV; Grimmond SM; ; Wessels LF; Wood SA; Iacobuzio-Donahue CA; Pilarsky C; Largaespada DA; Adams DJ; Tuveson DA
    Nature; 2012 Apr; 486(7402):266-70. PubMed ID: 22699621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclocommunol induces apoptosis in human oral squamous cell carcinoma partially through a Mcl-1-dependent mechanism.
    Weng JR; Bai LY; Ko HH; Tsai YT
    Phytomedicine; 2018 Jan; 39():25-32. PubMed ID: 29433680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein Levels of Anti-Apoptotic Mcl-1 and the Deubiquitinase USP9x Are Cooperatively Upregulated during Prostate Cancer Progression and Limit Response of Prostate Cancer Cells to Radiotherapy.
    Hogh-Binder SA; Klein D; Wolfsperger F; Huber SM; Hennenlotter J; Stenzl A; Rudner J
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mithramycin A inhibits myeloid cell leukemia-1 to induce apoptosis in oral squamous cell carcinomas and tumor xenograft through activation of Bax and oligomerization.
    Shin JA; Jung JY; Ryu MH; Safe S; Cho SD
    Mol Pharmacol; 2013 Jan; 83(1):33-41. PubMed ID: 23019217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usp9X Regulates Cell Death in Malignant Peripheral Nerve Sheath Tumors.
    Bianchetti E; Bates SJ; Carroll SL; Siegelin MD; Roth KA
    Sci Rep; 2018 Nov; 8(1):17390. PubMed ID: 30478285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mcl-1 is an important therapeutic target for oral squamous cell carcinomas.
    Maji S; Samal SK; Pattanaik L; Panda S; Quinn BA; Das SK; Sarkar D; Pellecchia M; Fisher PB; Dash R
    Oncotarget; 2015 Jun; 6(18):16623-37. PubMed ID: 26009874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usp9x Promotes Survival in Human Pancreatic Cancer and Its Inhibition Suppresses Pancreatic Ductal Adenocarcinoma In Vivo Tumor Growth.
    Pal A; Dziubinski M; Di Magliano MP; Simeone DM; Owens S; Thomas D; Peterson L; Potu H; Talpaz M; Donato NJ
    Neoplasia; 2018 Feb; 20(2):152-164. PubMed ID: 29248719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined inhibition of RAC1 and Bcl-2/Bcl-xL synergistically induces glioblastoma cell death through down-regulation of the Usp9X/Mcl-1 axis.
    Hlavac M; Dwucet A; Kast RE; Engelke J; Westhoff MA; Siegelin MD; Debatin KM; Wirtz CR; Halatsch ME; Karpel-Massler G
    Cell Oncol (Dordr); 2019 Jun; 42(3):287-301. PubMed ID: 30859392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FBXW7 affects autophagy through MCL1 in oral squamous cell carcinoma.
    Sun Y; Nie W; Qiu B; Yang Q; Zhao H
    Oral Dis; 2023 Nov; 29(8):3259-3267. PubMed ID: 38055341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of T-type calcium channel Cav3.1 in oral squamous cell carcinoma: association with proliferation and anti-apoptotic activity.
    Li RF; Man QW; Liu JY; Zheng YY; Gao X; Liu HM
    J Mol Histol; 2021 Jun; 52(3):511-520. PubMed ID: 33394292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contactin 1 (CNTN1) expression associates with regional lymph node metastasis and is a novel predictor of prognosis in patients with oral squamous cell carcinoma.
    Wu HM; Cao W; Ye D; Ren GX; Wu YN; Guo W
    Mol Med Rep; 2012 Aug; 6(2):265-70. PubMed ID: 22580838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. USP9X inhibition promotes radiation-induced apoptosis in non-small cell lung cancer cells expressing mid-to-high MCL1.
    Kushwaha D; O'Leary C; Cron KR; Deraska P; Zhu K; D'Andrea AD; Kozono D
    Cancer Biol Ther; 2015; 16(3):392-401. PubMed ID: 25692226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. UBE2S associated with OSCC proliferation by promotion of P21 degradation via the ubiquitin-proteasome system.
    Yoshimura S; Kasamatsu A; Nakashima D; Iyoda M; Kasama H; Saito T; Takahara T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
    Biochem Biophys Res Commun; 2017 Apr; 485(4):820-825. PubMed ID: 28257844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.